|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300077361 |
|
最近更新日期: Date of Last Refreshed on: |
2023-11-06 17:03:13 |
|
注册时间: Date of Registration: |
2023-11-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
刘氏正骨手法联合导引功法治疗腰椎间盘突出症关键技术规范与应用研究 |
|
Public title: |
Key technical specifications and application research of Liu's manual therapy combined with traditional Chinese exercises in the treatment of lumbar disc herniation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
刘氏正骨手法联合导引功法治疗腰椎间盘突出症关键技术规范与应用研究 |
|
Scientific title: |
Key technical specifications and application research of Liu's manual therapy combined with traditional Chinese exercises in the treatment of lumbar disc herniation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
范志鸿 |
研究负责人: |
张贤 |
|
Applicant: |
Zhihong Fan |
Study leader: |
Xian Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 137 7482 2613 |
研究负责人电话: Study leader's telephone: |
+86 136 1617 3567 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
fzh980922@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhangxian0772@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国江苏省无锡市滨湖区中南西路8号 |
研究负责人通讯地址: |
中国江苏省无锡市滨湖区中南西路8号 |
|
Applicant address: |
No. 8, Zhongnan West Road, Binhu District, Wuxi City, Jiangsu Province, China |
Study leader's address: |
No. 8, Zhongnan West Road, Binhu District, Wuxi City, Jiangsu Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
无锡市中医医院 |
||
|
Applicant's institution: |
Wuxi Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
无锡市中医医院 |
||
|
Affiliation of the Leader: |
Wuxi Hospital of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
STHZG2023021301 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
无锡市中医医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Wuxi Hospital of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-02-23 00:00:00 |
||
|
伦理委员会联系人: |
吴新宇 |
||
|
Contact Name of the ethic committee: |
Xinyu Wu |
||
|
伦理委员会联系地址: |
中国江苏省无锡市滨湖区中南西路8号 |
||
|
Contact Address of the ethic committee: |
No. 8, Zhongnan West Road, Binhu District, Wuxi City, Jiangsu Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 510 8270 3775 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
无锡市中医医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Wuxi Hospital of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国江苏省无锡市滨湖区中南西路8号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 8, Zhongnan West Road, Binhu District, Wuxi City, Jiangsu Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无锡市科技局 |
||||||||||||||||||||||
|
Source(s) of funding: |
Wuxi Science and Technology Bureau |
||||||||||||||||||||||
|
Target disease: |
lumbar disc herniation |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(1)建立并优化“刘氏骨伤疗法”中刘氏正骨手法联合导引功法治疗腰椎间盘突出症的关键技术规范方案; (2)验证关键技术规范方案临床应用的安全有效性,为临床决策提供证据支持; (3)推广腰椎间盘突出症推拿手法联合导引功法的特色诊疗模式,提高无锡地区腰椎间盘突出症中医非手术疗法诊治水平。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) To establish and optimize the key technical specifications for the treatment of lumbar intervertebral disc herniation by Liu's manual therapy of "Liu's Osteopathy" combined with traditional Chinese exercises; (2) To validate the safety and effectiveness of the key technical specifications for clinical application, and to provide evidence support for the clinical decision-making; (3) To promote the characteristic diagnostic and therapeutic modes of the lumbar intervertebral disc herniation by combining massage manipulation with guided gong method, and to increase the level of non-surgical Chinese medicine treatments of the lumbar intervertebral disc herniation in Wuxi area. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1: 年龄≥18 周岁且≤65 周岁,性别不限 2: 符合腰椎间盘突出症诊断标准 3: 病程≥3 个月 4: VAS 评分>3且≤7 5: 自愿参加本研究并签署知情同意书者 |
||||||||||||||||||||||
|
Inclusion criteria |
1: Age ≥18 years and ≤65 years, regardless of gender 2: Meet the diagnostic criteria for lumbar disc herniation 3: Duration of disease ≥3 months 4: VAS score >3mm and ≤7 5: Voluntarily participate in the study and sign the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
1: 既往严重脊柱创伤史 2: 影像学 所见有脊柱骨质肿瘤、结核、骨质疏松等患者 3: 有严重神经功能缺损,如马尾神经损伤 4: 合并心血管、脑血管、造血、消化系统等严重疾病或精神病患者 5: 有其他自身免疫性疾病、变态反应性疾病和急、慢性感染者 6: 近 3 个月内参加其他临床试验者 |
||||||||||||||||||||||
|
Exclusion criteria: |
1: History of previous severe spinal trauma 2: Imaging Patients seen with spinal bone tumors, tuberculosis, osteoporosis, etc. 3: Serious neurological deficits, such as cauda equina injury. 4: Combined cardiovascular, cerebrovascular, hematopoietic, digestive system and other serious diseases or psychiatric patients 5: Patients with other autoimmune diseases, allergic diseases and acute or chronic infections. 6: Participating in other clinical trials within the last 3 months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-11-10 00:00:00至 To 2024-11-10 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-11-10 00:00:00 至 To 2023-11-10 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用中心随机法,随机序列将由一个中央随机系统产生,通过中央随机化系统产生随机数字和分组分配并将其提供给研究人员,该研究人员不参与试验任何其他过程。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
With central randomization, the random sequence will be generated by a central randomization system, and the random numbers and group assignments will be provided through the central randomization system to an independent researcher who is not involved in any other process of the trial |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
患者、疗效评价及统计分析人员施盲。 |
|
Blinding: |
Patients, efficacy evaluation, and statistical analysis personnel are blinded. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病历记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |